Enochian Biosciences Aktie

0,0462 EUR -0,0530 EUR -53,43 %

08:07:35

FSE

0,1278 USD -0,0128 USD -9,10 %

nachbörslich10:54:18

BTT

Enochian Biosciences jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.25,72 Mio. EUR

Div. Rendite0,00%

WKNA2PBYQ

ISINUS29350E1047

SymbolRENB

Enochian Biosciences Aktien News

Sortieren:Datum Meistgelesen

04.04.25GlobeNewswireRenovaro Provides Update to Definitive Agreement with Predictive Oncology

03.03.25GlobeNewswireRenovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

26.02.25GlobeNewswireRenovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

WerbungEnochian Biosciences-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

26.02.25GlobeNewswireRenovaro Announces $15 million in Equity Committed

07.01.25GlobeNewswireRenovaro Issues Shareholder Letter and Provides Corporate Update

07.01.25GlobeNewswireRenovaro Appoints Nathen Fuentes as Chief Financial Officer

06.01.25GlobeNewswireRenovaro to Acquire Predictive Oncology in All-Stock Transaction

30.12.24GlobeNewswireRenovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

23.12.24GlobeNewswireRenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

20.12.24GlobeNewswireRenovaro Regains Compliance with NASDAQ Listing Requirement

20.12.24GlobeNewswireRenovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

04.11.24GlobeNewswireRenovaro Issues Shareholder Letter and Provides Corporate Update

17.10.24GlobeNewswireRenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

16.10.24GlobeNewswireRenovaro Announces Strategic Restructuring and Leadership Transition

19.09.24GlobeNewswirePersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics

17.09.24GlobeNewswireIndependent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection

13.09.24GlobeNewswireRenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

11.09.24GlobeNewswireRenovaroCube Announces Strategic Offering of Up to 20% Ownership

14.06.24GlobeNewswireRenovaro, Inc. Announces $10 million in Equity Committed

24.05.24GlobeNewswireRenovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy

30.04.24GlobeNewswireTransforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

24.04.24GlobeNewswireRenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

18.04.24GlobeNewswireRenovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Missio

12.03.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB

03.03.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB

24.02.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB

17.02.24PR NewswireROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB

16.02.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB

15.02.24GlobeNewswireCutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

14.02.24GlobeNewswireStatement of Renovaro Inc

13.02.24GlobeNewswireCutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

13.02.24GlobeNewswireAI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

25.01.24GlobeNewswireRenovaro Biosciences Announces Results of Special Meeting of Shareholders

16.01.24GlobeNewswireMessage from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD

11.10.23GlobeNewswireAvram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors

10.10.23GlobeNewswireRenovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors

02.10.23GlobeNewswireAI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine

29.09.23PR NewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APRN, RENB, TALS, WMC

29.09.23GlobeNewswireRenovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine

30.08.23GlobeNewswireRenovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort

Enochian Biosciences News

Enochian Biosciences News: auf dieser Seite finden Sie alle Enochian Biosciences News und Nachrichten zur Enochian Biosciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Enochian Biosciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Enochian Biosciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.